nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ENPP1—type 2 diabetes mellitus	0.728	1	CbGaD
Amifostine—ALPPL2—forelimb zeugopod—type 2 diabetes mellitus	0.0221	0.234	CbGeAlD
Amifostine—ALPPL2—brown adipose tissue—type 2 diabetes mellitus	0.0139	0.147	CbGeAlD
Amifostine—ALPPL2—leg—type 2 diabetes mellitus	0.0112	0.118	CbGeAlD
Amifostine—ALPPL2—hindlimb—type 2 diabetes mellitus	0.00997	0.106	CbGeAlD
Amifostine—ALPPL2—artery—type 2 diabetes mellitus	0.00611	0.0648	CbGeAlD
Amifostine—ALPPL2—endothelium—type 2 diabetes mellitus	0.00516	0.0548	CbGeAlD
Amifostine—ALPL—NOTCH1 regulation of human endothelial cell calcification—PLAT—type 2 diabetes mellitus	0.00373	0.0585	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—ENPP1—type 2 diabetes mellitus	0.00297	0.0466	CbGpPWpGaD
Amifostine—ALPL—nephron tubule—type 2 diabetes mellitus	0.00267	0.0283	CbGeAlD
Amifostine—ENPP1—Insulin Signaling—PPP1R3A—type 2 diabetes mellitus	0.00248	0.039	CbGpPWpGaD
Amifostine—ALPPL2—nephron tubule—type 2 diabetes mellitus	0.00237	0.0251	CbGeAlD
Amifostine—ALPL—cortex of kidney—type 2 diabetes mellitus	0.00229	0.0243	CbGeAlD
Amifostine—ENPP1—cardiovascular system—type 2 diabetes mellitus	0.0022	0.0234	CbGeAlD
Amifostine—ENPP1—kidney—type 2 diabetes mellitus	0.00216	0.0229	CbGeAlD
Amifostine—ALPPL2—cardiovascular system—type 2 diabetes mellitus	0.00212	0.0225	CbGeAlD
Amifostine—ALPL—adipose tissue—type 2 diabetes mellitus	0.00212	0.0224	CbGeAlD
Amifostine—ALPPL2—kidney—type 2 diabetes mellitus	0.00208	0.022	CbGeAlD
Amifostine—ENPP1—adipose tissue—type 2 diabetes mellitus	0.00194	0.0206	CbGeAlD
Amifostine—ALPPL2—adipose tissue—type 2 diabetes mellitus	0.00187	0.0199	CbGeAlD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—ACACA—type 2 diabetes mellitus	0.00168	0.0263	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—GRB14—type 2 diabetes mellitus	0.00151	0.0236	CbGpPWpGaD
Amifostine—ALPL—liver—type 2 diabetes mellitus	0.00148	0.0157	CbGeAlD
Amifostine—ALPL—AGE/RAGE pathway—INSR—type 2 diabetes mellitus	0.00147	0.023	CbGpPWpGaD
Amifostine—ENPP1—liver—type 2 diabetes mellitus	0.00136	0.0145	CbGeAlD
Amifostine—ALPPL2—liver—type 2 diabetes mellitus	0.00131	0.0139	CbGeAlD
Amifostine—ALPL—Endochondral Ossification—PLAT—type 2 diabetes mellitus	0.00129	0.0203	CbGpPWpGaD
Amifostine—ALPL—NOTCH1 regulation of human endothelial cell calcification—VEGFA—type 2 diabetes mellitus	0.00121	0.019	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—PLAT—type 2 diabetes mellitus	0.0011	0.0172	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—MTR—type 2 diabetes mellitus	0.00104	0.0163	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—SOD1—type 2 diabetes mellitus	0.00103	0.0161	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—type 2 diabetes mellitus	0.00102	0.016	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—IGF2—type 2 diabetes mellitus	0.001	0.0157	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—IGF1R—type 2 diabetes mellitus	0.000968	0.0152	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—PRKAA1—type 2 diabetes mellitus	0.000923	0.0145	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—AGER—type 2 diabetes mellitus	0.000889	0.0139	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—IGF2—type 2 diabetes mellitus	0.000851	0.0133	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—IGF1R—type 2 diabetes mellitus	0.000823	0.0129	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—type 2 diabetes mellitus	0.00082	0.0129	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—CALM1—type 2 diabetes mellitus	0.00078	0.0122	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—HIF1A—type 2 diabetes mellitus	0.000777	0.0122	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PRKAA1—type 2 diabetes mellitus	0.000722	0.0113	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—PRKCB—type 2 diabetes mellitus	0.000716	0.0112	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—NOS2—type 2 diabetes mellitus	0.000707	0.0111	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—IRS1—type 2 diabetes mellitus	0.000677	0.0106	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—CALM1—type 2 diabetes mellitus	0.000664	0.0104	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—INS—type 2 diabetes mellitus	0.000648	0.0102	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—IGF1—type 2 diabetes mellitus	0.000643	0.0101	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—CASP8—type 2 diabetes mellitus	0.000638	0.01	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—INSR—type 2 diabetes mellitus	0.000614	0.00962	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—NOS3—type 2 diabetes mellitus	0.000568	0.00891	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—SNAP25—type 2 diabetes mellitus	0.000557	0.00874	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—type 2 diabetes mellitus	0.000556	0.00871	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—IGF1—type 2 diabetes mellitus	0.000546	0.00857	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—RELA—type 2 diabetes mellitus	0.000535	0.00839	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—SLC2A1—type 2 diabetes mellitus	0.000504	0.0079	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PTPN1—type 2 diabetes mellitus	0.000483	0.00757	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—SLC2A4—type 2 diabetes mellitus	0.000483	0.00757	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—CASP3—type 2 diabetes mellitus	0.000483	0.00757	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—MMP9—type 2 diabetes mellitus	0.000467	0.00733	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MMP9—type 2 diabetes mellitus	0.000456	0.00715	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—PPP2CA—type 2 diabetes mellitus	0.000455	0.00714	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—NFKB1—type 2 diabetes mellitus	0.000451	0.00708	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—SRC—type 2 diabetes mellitus	0.000421	0.00659	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—VEGFA—type 2 diabetes mellitus	0.00042	0.00658	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—IRS2—type 2 diabetes mellitus	0.000415	0.00651	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—MMP9—type 2 diabetes mellitus	0.000397	0.00623	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—IGF1R—type 2 diabetes mellitus	0.000395	0.0062	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—TGFB1—type 2 diabetes mellitus	0.000385	0.00604	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—EGFR—type 2 diabetes mellitus	0.000369	0.00578	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—IRS1—type 2 diabetes mellitus	0.000363	0.00569	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—VEGFA—type 2 diabetes mellitus	0.000357	0.0056	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—type 2 diabetes mellitus	0.000354	0.00556	CbGpPWpGaD
Amifostine—ENPP1—Disease—VPS26A—type 2 diabetes mellitus	0.000332	0.0052	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—TGFB1—type 2 diabetes mellitus	0.000328	0.00514	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—IRS2—type 2 diabetes mellitus	0.000325	0.00509	CbGpPWpGaD
Amifostine—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000313	0.00274	CcSEcCtD
Amifostine—Loss of consciousness—Bromocriptine—type 2 diabetes mellitus	0.000313	0.00273	CcSEcCtD
Amifostine—Flushing—Gliclazide—type 2 diabetes mellitus	0.000311	0.00272	CcSEcCtD
Amifostine—Nausea—Tolazamide—type 2 diabetes mellitus	0.000309	0.0027	CcSEcCtD
Amifostine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000309	0.0027	CcSEcCtD
Amifostine—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.000308	0.00269	CcSEcCtD
Amifostine—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000307	0.00269	CcSEcCtD
Amifostine—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.000307	0.00269	CcSEcCtD
Amifostine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000307	0.00269	CcSEcCtD
Amifostine—Somnolence—Glipizide—type 2 diabetes mellitus	0.000306	0.00268	CcSEcCtD
Amifostine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000306	0.00268	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—PIK3R1—type 2 diabetes mellitus	0.000305	0.00478	CbGpPWpGaD
Amifostine—Rash—Nateglinide—type 2 diabetes mellitus	0.000304	0.00265	CcSEcCtD
Amifostine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000303	0.00265	CcSEcCtD
Amifostine—Chills—Gliclazide—type 2 diabetes mellitus	0.000301	0.00263	CcSEcCtD
Amifostine—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000301	0.00263	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PRKCB—type 2 diabetes mellitus	0.0003	0.0047	CbGpPWpGaD
Amifostine—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.0003	0.00262	CcSEcCtD
Amifostine—Nausea—Acarbose—type 2 diabetes mellitus	0.000297	0.00259	CcSEcCtD
Amifostine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000295	0.00258	CcSEcCtD
Amifostine—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000294	0.00258	CcSEcCtD
Amifostine—Acute coronary syndrome—Irbesartan—type 2 diabetes mellitus	0.000291	0.00254	CcSEcCtD
Amifostine—Renal failure—Irbesartan—type 2 diabetes mellitus	0.00029	0.00254	CcSEcCtD
Amifostine—Myocardial infarction—Irbesartan—type 2 diabetes mellitus	0.000289	0.00253	CcSEcCtD
Amifostine—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000287	0.00251	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—RELA—type 2 diabetes mellitus	0.000287	0.0045	CbGpPWpGaD
Amifostine—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000286	0.0025	CcSEcCtD
Amifostine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000286	0.0025	CcSEcCtD
Amifostine—Bradycardia—Metformin—type 2 diabetes mellitus	0.000286	0.0025	CcSEcCtD
Amifostine—Shock—Bromocriptine—type 2 diabetes mellitus	0.000286	0.0025	CcSEcCtD
Amifostine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000285	0.00249	CcSEcCtD
Amifostine—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000284	0.00248	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—IRS1—type 2 diabetes mellitus	0.000283	0.00444	CbGpPWpGaD
Amifostine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000283	0.00248	CcSEcCtD
Amifostine—Convulsion—Glyburide—type 2 diabetes mellitus	0.000282	0.00246	CcSEcCtD
Amifostine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000279	0.00244	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000278	0.00243	CcSEcCtD
Amifostine—ENPP1—Metabolism—BHMT—type 2 diabetes mellitus	0.000278	0.00436	CbGpPWpGaD
Amifostine—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000275	0.00241	CcSEcCtD
Amifostine—Urticaria—Glipizide—type 2 diabetes mellitus	0.000274	0.0024	CcSEcCtD
Amifostine—Renal failure—Losartan—type 2 diabetes mellitus	0.000273	0.00239	CcSEcCtD
Amifostine—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000272	0.00238	CcSEcCtD
Amifostine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000271	0.00237	CcSEcCtD
Amifostine—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.000271	0.00237	CcSEcCtD
Amifostine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.00027	0.00236	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—AKT1—type 2 diabetes mellitus	0.000268	0.0042	CbGpPWpGaD
Amifostine—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000265	0.00232	CcSEcCtD
Amifostine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000265	0.00232	CcSEcCtD
Amifostine—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000264	0.00231	CcSEcCtD
Amifostine—Malaise—Gliclazide—type 2 diabetes mellitus	0.000263	0.0023	CcSEcCtD
Amifostine—Rash—Repaglinide—type 2 diabetes mellitus	0.000263	0.0023	CcSEcCtD
Amifostine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000262	0.0023	CcSEcCtD
Amifostine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000262	0.00229	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—AKT2—type 2 diabetes mellitus	0.000262	0.00411	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—AKT1—type 2 diabetes mellitus	0.000261	0.0041	CbGpPWpGaD
Amifostine—Shock—Glyburide—type 2 diabetes mellitus	0.000261	0.00228	CcSEcCtD
Amifostine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00026	0.00228	CcSEcCtD
Amifostine—Flushing—Metformin—type 2 diabetes mellitus	0.00026	0.00228	CcSEcCtD
Amifostine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000259	0.00226	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—CASP3—type 2 diabetes mellitus	0.000259	0.00405	CbGpPWpGaD
Amifostine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000258	0.00226	CcSEcCtD
Amifostine—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000257	0.00224	CcSEcCtD
Amifostine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000256	0.00224	CcSEcCtD
Amifostine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000255	0.00223	CcSEcCtD
Amifostine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000254	0.00222	CcSEcCtD
Amifostine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000253	0.00221	CcSEcCtD
Amifostine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000252	0.0022	CcSEcCtD
Amifostine—Chills—Metformin—type 2 diabetes mellitus	0.000252	0.0022	CcSEcCtD
Amifostine—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000249	0.00217	CcSEcCtD
Amifostine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000248	0.00217	CcSEcCtD
Amifostine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000248	0.00217	CcSEcCtD
Amifostine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000248	0.00217	CcSEcCtD
Amifostine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000248	0.00216	CcSEcCtD
Amifostine—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000246	0.00215	CcSEcCtD
Amifostine—Flushing—Irbesartan—type 2 diabetes mellitus	0.000246	0.00215	CcSEcCtD
Amifostine—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000246	0.00215	CcSEcCtD
Amifostine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000244	0.00213	CcSEcCtD
Amifostine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000243	0.00213	CcSEcCtD
Amifostine—ENPP1—Metabolism—PTGDS—type 2 diabetes mellitus	0.000243	0.00381	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—AANAT—type 2 diabetes mellitus	0.000243	0.00381	CbGpPWpGaD
Amifostine—ENPP1—Disease—SLC5A4—type 2 diabetes mellitus	0.000242	0.0038	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—NFKB1—type 2 diabetes mellitus	0.000242	0.00379	CbGpPWpGaD
Amifostine—Syncope—Valsartan—type 2 diabetes mellitus	0.000241	0.0021	CcSEcCtD
Amifostine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000239	0.00209	CcSEcCtD
Amifostine—Malaise—Orlistat—type 2 diabetes mellitus	0.000239	0.00209	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PIK3R1—type 2 diabetes mellitus	0.000238	0.00373	CbGpPWpGaD
Amifostine—Chills—Irbesartan—type 2 diabetes mellitus	0.000238	0.00208	CcSEcCtD
Amifostine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000237	0.00207	CcSEcCtD
Amifostine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000237	0.00207	CcSEcCtD
Amifostine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000237	0.00207	CcSEcCtD
Amifostine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000236	0.00207	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000236	0.00206	CcSEcCtD
Amifostine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000236	0.00206	CcSEcCtD
Amifostine—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000236	0.00206	CcSEcCtD
Amifostine—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000235	0.00205	CcSEcCtD
Amifostine—Renal failure—Ramipril—type 2 diabetes mellitus	0.000234	0.00205	CcSEcCtD
Amifostine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000234	0.00205	CcSEcCtD
Amifostine—ENPP1—Disease—G6PC—type 2 diabetes mellitus	0.000234	0.00367	CbGpPWpGaD
Amifostine—ENPP1—Disease—PPP1R3C—type 2 diabetes mellitus	0.000234	0.00367	CbGpPWpGaD
Amifostine—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000233	0.00204	CcSEcCtD
Amifostine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000233	0.00203	CcSEcCtD
Amifostine—Flushing—Losartan—type 2 diabetes mellitus	0.000231	0.00202	CcSEcCtD
Amifostine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000231	0.00202	CcSEcCtD
Amifostine—ENPP1—Metabolism—CDO1—type 2 diabetes mellitus	0.00023	0.00361	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GPD2—type 2 diabetes mellitus	0.00023	0.00361	CbGpPWpGaD
Amifostine—Convulsion—Orlistat—type 2 diabetes mellitus	0.00023	0.00201	CcSEcCtD
Amifostine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000229	0.00201	CcSEcCtD
Amifostine—Chest pain—Valsartan—type 2 diabetes mellitus	0.000228	0.002	CcSEcCtD
Amifostine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000228	0.00199	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—AKT1—type 2 diabetes mellitus	0.000228	0.00357	CbGpPWpGaD
Amifostine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000228	0.00199	CcSEcCtD
Amifostine—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000227	0.00198	CcSEcCtD
Amifostine—Chest pain—Orlistat—type 2 diabetes mellitus	0.000226	0.00197	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—SRC—type 2 diabetes mellitus	0.000225	0.00353	CbGpPWpGaD
Amifostine—Discomfort—Orlistat—type 2 diabetes mellitus	0.000223	0.00195	CcSEcCtD
Amifostine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000223	0.00195	CcSEcCtD
Amifostine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000223	0.00195	CcSEcCtD
Amifostine—Malaise—Metformin—type 2 diabetes mellitus	0.00022	0.00193	CcSEcCtD
Amifostine—ENPP1—Metabolism—AK1—type 2 diabetes mellitus	0.00022	0.00345	CbGpPWpGaD
Amifostine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000219	0.00192	CcSEcCtD
Amifostine—Syncope—Metformin—type 2 diabetes mellitus	0.000219	0.00192	CcSEcCtD
Amifostine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000219	0.00191	CcSEcCtD
Amifostine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000219	0.00191	CcSEcCtD
Amifostine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000218	0.00191	CcSEcCtD
Amifostine—Rash—Glipizide—type 2 diabetes mellitus	0.000217	0.0019	CcSEcCtD
Amifostine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000217	0.0019	CcSEcCtD
Amifostine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000216	0.00189	CcSEcCtD
Amifostine—Shock—Valsartan—type 2 diabetes mellitus	0.000215	0.00188	CcSEcCtD
Amifostine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000215	0.00188	CcSEcCtD
Amifostine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000214	0.00187	CcSEcCtD
Amifostine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000213	0.00186	CcSEcCtD
Amifostine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000212	0.00186	CcSEcCtD
Amifostine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000212	0.00185	CcSEcCtD
Amifostine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000212	0.00185	CcSEcCtD
Amifostine—Hypertension—Metformin—type 2 diabetes mellitus	0.000211	0.00184	CcSEcCtD
Amifostine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000211	0.00184	CcSEcCtD
Amifostine—Chest pain—Metformin—type 2 diabetes mellitus	0.000208	0.00182	CcSEcCtD
Amifostine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000208	0.00182	CcSEcCtD
Amifostine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000207	0.00181	CcSEcCtD
Amifostine—Discomfort—Metformin—type 2 diabetes mellitus	0.000205	0.0018	CcSEcCtD
Amifostine—Nausea—Glipizide—type 2 diabetes mellitus	0.000205	0.00179	CcSEcCtD
Amifostine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000205	0.00179	CcSEcCtD
Amifostine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000205	0.00179	CcSEcCtD
Amifostine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000204	0.00178	CcSEcCtD
Amifostine—Rash—Glimepiride—type 2 diabetes mellitus	0.000203	0.00177	CcSEcCtD
Amifostine—ENPP1—Metabolism—MAT1A—type 2 diabetes mellitus	0.000203	0.00318	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000203	0.00318	CbGpPWpGaD
Amifostine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000203	0.00177	CcSEcCtD
Amifostine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000203	0.00177	CcSEcCtD
Amifostine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000202	0.00177	CcSEcCtD
Amifostine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000202	0.00177	CcSEcCtD
Amifostine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000202	0.00177	CcSEcCtD
Amifostine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000201	0.00176	CcSEcCtD
Amifostine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000199	0.00174	CcSEcCtD
Amifostine—ENPP1—Disease—ACACA—type 2 diabetes mellitus	0.000199	0.00312	CbGpPWpGaD
Amifostine—Flushing—Ramipril—type 2 diabetes mellitus	0.000198	0.00173	CcSEcCtD
Amifostine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000196	0.00172	CcSEcCtD
Amifostine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000196	0.00172	CcSEcCtD
Amifostine—Shock—Metformin—type 2 diabetes mellitus	0.000196	0.00172	CcSEcCtD
Amifostine—ENPP1—Metabolism—G6PC—type 2 diabetes mellitus	0.000196	0.00307	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000196	0.00307	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ND1—type 2 diabetes mellitus	0.000196	0.00307	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HBA2—type 2 diabetes mellitus	0.000196	0.00307	CbGpPWpGaD
Amifostine—Malaise—Losartan—type 2 diabetes mellitus	0.000196	0.00171	CcSEcCtD
Amifostine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000195	0.00171	CcSEcCtD
Amifostine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000195	0.00171	CcSEcCtD
Amifostine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000195	0.0017	CcSEcCtD
Amifostine—Syncope—Losartan—type 2 diabetes mellitus	0.000195	0.0017	CcSEcCtD
Amifostine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000194	0.0017	CcSEcCtD
Amifostine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000192	0.00168	CcSEcCtD
Amifostine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000191	0.00167	CcSEcCtD
Amifostine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000191	0.00167	CcSEcCtD
Amifostine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000191	0.00167	CcSEcCtD
Amifostine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00019	0.00167	CcSEcCtD
Amifostine—ENPP1—Metabolism—GCGR—type 2 diabetes mellitus	0.00019	0.00297	CbGpPWpGaD
Amifostine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000189	0.00166	CcSEcCtD
Amifostine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000188	0.00165	CcSEcCtD
Amifostine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000188	0.00165	CcSEcCtD
Amifostine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000188	0.00164	CcSEcCtD
Amifostine—Hypotension—Metformin—type 2 diabetes mellitus	0.000186	0.00163	CcSEcCtD
Amifostine—Shock—Irbesartan—type 2 diabetes mellitus	0.000185	0.00162	CcSEcCtD
Amifostine—Chest pain—Losartan—type 2 diabetes mellitus	0.000185	0.00162	CcSEcCtD
Amifostine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000185	0.00161	CcSEcCtD
Amifostine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000184	0.00161	CcSEcCtD
Amifostine—ENPP1—Disease—SLC5A2—type 2 diabetes mellitus	0.000183	0.00288	CbGpPWpGaD
Amifostine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000183	0.0016	CcSEcCtD
Amifostine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000183	0.0016	CcSEcCtD
Amifostine—Discomfort—Losartan—type 2 diabetes mellitus	0.000182	0.0016	CcSEcCtD
Amifostine—ENPP1—Metabolism—OXCT1—type 2 diabetes mellitus	0.000179	0.00281	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CYTB—type 2 diabetes mellitus	0.000179	0.00281	CbGpPWpGaD
Amifostine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000178	0.00156	CcSEcCtD
Amifostine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000178	0.00155	CcSEcCtD
Amifostine—Somnolence—Metformin—type 2 diabetes mellitus	0.000177	0.00155	CcSEcCtD
Amifostine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000177	0.00155	CcSEcCtD
Amifostine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000176	0.00154	CcSEcCtD
Amifostine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000176	0.00154	CcSEcCtD
Amifostine—ENPP1—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000175	0.00274	CbGpPWpGaD
Amifostine—Shock—Losartan—type 2 diabetes mellitus	0.000174	0.00152	CcSEcCtD
Amifostine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000174	0.00152	CcSEcCtD
Amifostine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000173	0.00151	CcSEcCtD
Amifostine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000173	0.00151	CcSEcCtD
Amifostine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000172	0.00151	CcSEcCtD
Amifostine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000172	0.0015	CcSEcCtD
Amifostine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000171	0.0015	CcSEcCtD
Amifostine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000169	0.00148	CcSEcCtD
Amifostine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000169	0.00147	CcSEcCtD
Amifostine—Malaise—Ramipril—type 2 diabetes mellitus	0.000168	0.00147	CcSEcCtD
Amifostine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000168	0.00147	CcSEcCtD
Amifostine—Rash—Glyburide—type 2 diabetes mellitus	0.000167	0.00146	CcSEcCtD
Amifostine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000167	0.00146	CcSEcCtD
Amifostine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000167	0.00146	CcSEcCtD
Amifostine—Syncope—Ramipril—type 2 diabetes mellitus	0.000167	0.00146	CcSEcCtD
Amifostine—ENPP1—Disease—PCK1—type 2 diabetes mellitus	0.000167	0.00261	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000167	0.00261	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ACACA—type 2 diabetes mellitus	0.000167	0.00261	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—STAR—type 2 diabetes mellitus	0.000167	0.00261	CbGpPWpGaD
Amifostine—Hypotension—Losartan—type 2 diabetes mellitus	0.000165	0.00145	CcSEcCtD
Amifostine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000164	0.00144	CcSEcCtD
Amifostine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000163	0.00143	CcSEcCtD
Amifostine—ENPP1—Disease—TLE4—type 2 diabetes mellitus	0.000162	0.00254	CbGpPWpGaD
Amifostine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000161	0.00141	CcSEcCtD
Amifostine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000161	0.00141	CcSEcCtD
Amifostine—ENPP1—Metabolism—ABCC8—type 2 diabetes mellitus	0.00016	0.0025	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CBS—type 2 diabetes mellitus	0.00016	0.0025	CbGpPWpGaD
Amifostine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000159	0.00139	CcSEcCtD
Amifostine—Urticaria—Metformin—type 2 diabetes mellitus	0.000158	0.00138	CcSEcCtD
Amifostine—Chest pain—Ramipril—type 2 diabetes mellitus	0.000158	0.00138	CcSEcCtD
Amifostine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000158	0.00138	CcSEcCtD
Amifostine—Nausea—Glyburide—type 2 diabetes mellitus	0.000158	0.00138	CcSEcCtD
Amifostine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000158	0.00138	CcSEcCtD
Amifostine—Somnolence—Losartan—type 2 diabetes mellitus	0.000157	0.00138	CcSEcCtD
Amifostine—Discomfort—Ramipril—type 2 diabetes mellitus	0.000156	0.00137	CcSEcCtD
Amifostine—ENPP1—Disease—HK1—type 2 diabetes mellitus	0.000156	0.00245	CbGpPWpGaD
Amifostine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000155	0.00136	CcSEcCtD
Amifostine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000155	0.00135	CcSEcCtD
Amifostine—ENPP1—Metabolism—COX2—type 2 diabetes mellitus	0.000154	0.00241	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000154	0.00241	CbGpPWpGaD
Amifostine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000153	0.00134	CcSEcCtD
Amifostine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000152	0.00133	CcSEcCtD
Amifostine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000151	0.00132	CcSEcCtD
Amifostine—ENPP1—Metabolism—NCOA6—type 2 diabetes mellitus	0.000151	0.00237	CbGpPWpGaD
Amifostine—ENPP1—Disease—GCKR—type 2 diabetes mellitus	0.000151	0.00236	CbGpPWpGaD
Amifostine—Rash—Gliclazide—type 2 diabetes mellitus	0.00015	0.00131	CcSEcCtD
Amifostine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00015	0.00131	CcSEcCtD
Amifostine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000149	0.00131	CcSEcCtD
Amifostine—Shock—Ramipril—type 2 diabetes mellitus	0.000149	0.00131	CcSEcCtD
Amifostine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000149	0.0013	CcSEcCtD
Amifostine—ENPP1—Metabolism—UCP2—type 2 diabetes mellitus	0.000148	0.00233	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—UCP3—type 2 diabetes mellitus	0.000148	0.00233	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000148	0.00233	CbGpPWpGaD
Amifostine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000148	0.0013	CcSEcCtD
Amifostine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000146	0.00128	CcSEcCtD
Amifostine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000145	0.00127	CcSEcCtD
Amifostine—ENPP1—Disease—ALDOB—type 2 diabetes mellitus	0.000144	0.00227	CbGpPWpGaD
Amifostine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000143	0.00125	CcSEcCtD
Amifostine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000142	0.00124	CcSEcCtD
Amifostine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000142	0.00124	CcSEcCtD
Amifostine—Pruritus—Metformin—type 2 diabetes mellitus	0.000141	0.00123	CcSEcCtD
Amifostine—Urticaria—Losartan—type 2 diabetes mellitus	0.000141	0.00123	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—AKT1—type 2 diabetes mellitus	0.00014	0.0022	CbGpPWpGaD
Amifostine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00014	0.00122	CcSEcCtD
Amifostine—ENPP1—Metabolism—PCK1—type 2 diabetes mellitus	0.00014	0.00219	CbGpPWpGaD
Amifostine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000139	0.00122	CcSEcCtD
Amifostine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000139	0.00121	CcSEcCtD
Amifostine—Rash—Valsartan—type 2 diabetes mellitus	0.000138	0.00121	CcSEcCtD
Amifostine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000138	0.00121	CcSEcCtD
Amifostine—ENPP1—Disease—SPRY2—type 2 diabetes mellitus	0.000138	0.00216	CbGpPWpGaD
Amifostine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000138	0.0012	CcSEcCtD
Amifostine—Rash—Orlistat—type 2 diabetes mellitus	0.000136	0.00119	CcSEcCtD
Amifostine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000136	0.00119	CcSEcCtD
Amifostine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000135	0.00118	CcSEcCtD
Amifostine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000135	0.00118	CcSEcCtD
Amifostine—ENPP1—Disease—RBP4—type 2 diabetes mellitus	0.000134	0.00211	CbGpPWpGaD
Amifostine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000133	0.00116	CcSEcCtD
Amifostine—Dizziness—Metformin—type 2 diabetes mellitus	0.000132	0.00115	CcSEcCtD
Amifostine—ENPP1—Metabolism—HK1—type 2 diabetes mellitus	0.000131	0.00205	CbGpPWpGaD
Amifostine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00013	0.00114	CcSEcCtD
Amifostine—Nausea—Valsartan—type 2 diabetes mellitus	0.00013	0.00114	CcSEcCtD
Amifostine—Nausea—Orlistat—type 2 diabetes mellitus	0.000128	0.00112	CcSEcCtD
Amifostine—Vomiting—Metformin—type 2 diabetes mellitus	0.000127	0.00111	CcSEcCtD
Amifostine—ENPP1—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000126	0.00198	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000126	0.00198	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GCKR—type 2 diabetes mellitus	0.000126	0.00198	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—LPA—type 2 diabetes mellitus	0.000126	0.00198	CbGpPWpGaD
Amifostine—Rash—Metformin—type 2 diabetes mellitus	0.000126	0.0011	CcSEcCtD
Amifostine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000126	0.0011	CcSEcCtD
Amifostine—ENPP1—Disease—SLC2A2—type 2 diabetes mellitus	0.000125	0.00197	CbGpPWpGaD
Amifostine—Pruritus—Losartan—type 2 diabetes mellitus	0.000125	0.0011	CcSEcCtD
Amifostine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000125	0.00109	CcSEcCtD
Amifostine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000124	0.00109	CcSEcCtD
Amifostine—ENPP1—Disease—MTR—type 2 diabetes mellitus	0.000123	0.00193	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ALDOB—type 2 diabetes mellitus	0.000121	0.0019	CbGpPWpGaD
Amifostine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000121	0.00105	CcSEcCtD
Amifostine—ENPP1—Disease—NAMPT—type 2 diabetes mellitus	0.00012	0.00189	CbGpPWpGaD
Amifostine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00012	0.00105	CcSEcCtD
Amifostine—ENPP1—Disease—GCK—type 2 diabetes mellitus	0.00012	0.00188	CbGpPWpGaD
Amifostine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00012	0.00105	CcSEcCtD
Amifostine—ENPP1—Disease—IAPP—type 2 diabetes mellitus	0.000119	0.00187	CbGpPWpGaD
Amifostine—Rash—Irbesartan—type 2 diabetes mellitus	0.000119	0.00104	CcSEcCtD
Amifostine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000118	0.00104	CcSEcCtD
Amifostine—Nausea—Metformin—type 2 diabetes mellitus	0.000118	0.00104	CcSEcCtD
Amifostine—Dizziness—Losartan—type 2 diabetes mellitus	0.000117	0.00102	CcSEcCtD
Amifostine—ENPP1—Disease—SLC9A1—type 2 diabetes mellitus	0.000117	0.00183	CbGpPWpGaD
Amifostine—Vomiting—Losartan—type 2 diabetes mellitus	0.000113	0.000984	CcSEcCtD
Amifostine—ENPP1—Metabolism—GLP1R—type 2 diabetes mellitus	0.000112	0.00176	CbGpPWpGaD
Amifostine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000112	0.000978	CcSEcCtD
Amifostine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000112	0.000977	CcSEcCtD
Amifostine—Rash—Losartan—type 2 diabetes mellitus	0.000112	0.000976	CcSEcCtD
Amifostine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000112	0.000975	CcSEcCtD
Amifostine—ENPP1—Disease—HMGA1—type 2 diabetes mellitus	0.000109	0.00172	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—AKT1—type 2 diabetes mellitus	0.000109	0.00172	CbGpPWpGaD
Amifostine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000107	0.000939	CcSEcCtD
Amifostine—ENPP1—Disease—PSMD6—type 2 diabetes mellitus	0.000107	0.00168	CbGpPWpGaD
Amifostine—ENPP1—Disease—SNAP25—type 2 diabetes mellitus	0.000107	0.00168	CbGpPWpGaD
Amifostine—Nausea—Losartan—type 2 diabetes mellitus	0.000105	0.00092	CcSEcCtD
Amifostine—ENPP1—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000105	0.00165	CbGpPWpGaD
Amifostine—ENPP1—Disease—CYBA—type 2 diabetes mellitus	0.000104	0.00163	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—MTR—type 2 diabetes mellitus	0.000103	0.00161	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CPT1A—type 2 diabetes mellitus	0.000103	0.00161	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NAMPT—type 2 diabetes mellitus	0.000101	0.00158	CbGpPWpGaD
Amifostine—ENPP1—Disease—CALCA—type 2 diabetes mellitus	0.000101	0.00158	CbGpPWpGaD
Amifostine—Dizziness—Ramipril—type 2 diabetes mellitus	0.0001	0.000878	CcSEcCtD
Amifostine—ENPP1—Metabolism—HBA1—type 2 diabetes mellitus	0.0001	0.00157	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GCK—type 2 diabetes mellitus	0.0001	0.00157	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—LIPC—type 2 diabetes mellitus	0.0001	0.00157	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CYP11A1—type 2 diabetes mellitus	9.96e-05	0.00156	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SLC9A1—type 2 diabetes mellitus	9.78e-05	0.00153	CbGpPWpGaD
Amifostine—ENPP1—Disease—SLC2A1—type 2 diabetes mellitus	9.71e-05	0.00152	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CETP—type 2 diabetes mellitus	9.67e-05	0.00152	CbGpPWpGaD
Amifostine—Vomiting—Ramipril—type 2 diabetes mellitus	9.65e-05	0.000844	CcSEcCtD
Amifostine—Rash—Ramipril—type 2 diabetes mellitus	9.57e-05	0.000837	CcSEcCtD
Amifostine—ENPP1—Disease—NOS1—type 2 diabetes mellitus	9.57e-05	0.0015	CbGpPWpGaD
Amifostine—Dermatitis—Ramipril—type 2 diabetes mellitus	9.56e-05	0.000836	CcSEcCtD
Amifostine—ENPP1—Disease—TCF7L2—type 2 diabetes mellitus	9.47e-05	0.00148	CbGpPWpGaD
Amifostine—ENPP1—Disease—SLC2A4—type 2 diabetes mellitus	9.31e-05	0.00146	CbGpPWpGaD
Amifostine—Nausea—Ramipril—type 2 diabetes mellitus	9.02e-05	0.000789	CcSEcCtD
Amifostine—ENPP1—Metabolism—PSMD6—type 2 diabetes mellitus	8.99e-05	0.00141	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SNAP25—type 2 diabetes mellitus	8.99e-05	0.00141	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SREBF1—type 2 diabetes mellitus	8.99e-05	0.00141	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CTGF—type 2 diabetes mellitus	8.83e-05	0.00138	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HMGCR—type 2 diabetes mellitus	8.75e-05	0.00137	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ADRA2A—type 2 diabetes mellitus	8.56e-05	0.00134	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CYP2E1—type 2 diabetes mellitus	8.22e-05	0.00129	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SLC2A1—type 2 diabetes mellitus	8.13e-05	0.00128	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CYP1A2—type 2 diabetes mellitus	8.13e-05	0.00128	CbGpPWpGaD
Amifostine—ENPP1—Disease—TGFBR2—type 2 diabetes mellitus	8.1e-05	0.00127	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CYP3A4—type 2 diabetes mellitus	7.93e-05	0.00124	CbGpPWpGaD
Amifostine—ENPP1—Disease—CDKN2B—type 2 diabetes mellitus	7.85e-05	0.00123	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GCG—type 2 diabetes mellitus	7.8e-05	0.00122	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SLC2A4—type 2 diabetes mellitus	7.8e-05	0.00122	CbGpPWpGaD
Amifostine—ENPP1—Disease—APOB—type 2 diabetes mellitus	7.65e-05	0.0012	CbGpPWpGaD
Amifostine—ENPP1—Disease—LPL—type 2 diabetes mellitus	7.3e-05	0.00115	CbGpPWpGaD
Amifostine—ENPP1—Disease—ADCY5—type 2 diabetes mellitus	7.15e-05	0.00112	CbGpPWpGaD
Amifostine—ENPP1—Disease—PPP2CA—type 2 diabetes mellitus	6.85e-05	0.00107	CbGpPWpGaD
Amifostine—ENPP1—Disease—CCR5—type 2 diabetes mellitus	6.73e-05	0.00106	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GNB3—type 2 diabetes mellitus	6.72e-05	0.00105	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.72e-05	0.00105	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HMOX1—type 2 diabetes mellitus	6.69e-05	0.00105	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CAT—type 2 diabetes mellitus	6.6e-05	0.00103	CbGpPWpGaD
Amifostine—ENPP1—Disease—MTHFR—type 2 diabetes mellitus	6.58e-05	0.00103	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—APOB—type 2 diabetes mellitus	6.41e-05	0.001	CbGpPWpGaD
Amifostine—ENPP1—Disease—HIF1A—type 2 diabetes mellitus	6.27e-05	0.000984	CbGpPWpGaD
Amifostine—ENPP1—Disease—IRS2—type 2 diabetes mellitus	6.26e-05	0.000981	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTM1—type 2 diabetes mellitus	6.23e-05	0.000977	CbGpPWpGaD
Amifostine—ENPP1—Disease—CALM1—type 2 diabetes mellitus	6.14e-05	0.000964	CbGpPWpGaD
Amifostine—ENPP1—Disease—APOE—type 2 diabetes mellitus	6.12e-05	0.00096	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—LPL—type 2 diabetes mellitus	6.12e-05	0.000959	CbGpPWpGaD
Amifostine—ENPP1—Disease—APOA1—type 2 diabetes mellitus	6.05e-05	0.000949	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ADCY5—type 2 diabetes mellitus	5.99e-05	0.000939	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GPX1—type 2 diabetes mellitus	5.97e-05	0.000936	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CD36—type 2 diabetes mellitus	5.81e-05	0.000912	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.74e-05	0.0009	CbGpPWpGaD
Amifostine—ENPP1—Disease—NOS2—type 2 diabetes mellitus	5.71e-05	0.000895	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—MTHFR—type 2 diabetes mellitus	5.51e-05	0.000864	CbGpPWpGaD
Amifostine—ENPP1—Disease—IRS1—type 2 diabetes mellitus	5.46e-05	0.000857	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PPARA—type 2 diabetes mellitus	5.4e-05	0.000847	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—AGT—type 2 diabetes mellitus	5.23e-05	0.000821	CbGpPWpGaD
Amifostine—ENPP1—Disease—INS—type 2 diabetes mellitus	5.23e-05	0.00082	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CALM1—type 2 diabetes mellitus	5.15e-05	0.000807	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—APOE—type 2 diabetes mellitus	5.13e-05	0.000804	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—APOA1—type 2 diabetes mellitus	5.07e-05	0.000795	CbGpPWpGaD
Amifostine—ENPP1—Disease—AKT2—type 2 diabetes mellitus	5.06e-05	0.000793	CbGpPWpGaD
Amifostine—ENPP1—Disease—SERPINE1—type 2 diabetes mellitus	4.8e-05	0.000753	CbGpPWpGaD
Amifostine—ENPP1—Disease—NOS3—type 2 diabetes mellitus	4.59e-05	0.000719	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3R1—type 2 diabetes mellitus	4.59e-05	0.000719	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PPARG—type 2 diabetes mellitus	4.47e-05	0.0007	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—INS—type 2 diabetes mellitus	4.38e-05	0.000687	CbGpPWpGaD
Amifostine—ENPP1—Disease—PTGS2—type 2 diabetes mellitus	4.2e-05	0.000658	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ALB—type 2 diabetes mellitus	4.02e-05	0.00063	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NOS3—type 2 diabetes mellitus	3.84e-05	0.000602	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.84e-05	0.000602	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTGS2—type 2 diabetes mellitus	3.51e-05	0.000551	CbGpPWpGaD
Amifostine—ENPP1—Disease—SRC—type 2 diabetes mellitus	3.39e-05	0.000532	CbGpPWpGaD
Amifostine—ENPP1—Disease—TGFB1—type 2 diabetes mellitus	3.03e-05	0.000476	CbGpPWpGaD
Amifostine—ENPP1—Disease—EGFR—type 2 diabetes mellitus	2.97e-05	0.000466	CbGpPWpGaD
Amifostine—ENPP1—Disease—IL6—type 2 diabetes mellitus	2.29e-05	0.000358	CbGpPWpGaD
Amifostine—ENPP1—Disease—AKT1—type 2 diabetes mellitus	2.11e-05	0.000331	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—AKT1—type 2 diabetes mellitus	1.77e-05	0.000277	CbGpPWpGaD
